Financial Express (Holdings) Limited (“we”, “our”, “us” and derivatives) are committed to protecting and respecting your privacy. This Privacy Policy, together with our Terms of Use, sets out the basis on which any personal data that we collect from you, or that you provide to us, will be processed by us relating to your use of any of the below websites (“sites”).


For the purposes of the Data Protection Act 1998, the data controller is Trustnet Limited of 2nd Floor, Golden House, 30 Great Pulteney Street, London, W1F 9NN. Our nominated representative for the purpose of this Act is Kirsty Witter.


We collect information about you when you register with us or use any of our websites / services. Part of the registration process may include entering personal details & details of your investments.

We may collect information about your computer, including where available your operating system, browser version, domain name and IP address and details of the website that you came from, in order to improve this site.

You confirm that all information you supply is accurate.


In order to provide personalised services to and analyse site traffic, we may use a cookie file which is stored on your browser or the hard drive of your computer. Some of the cookies we use are essential for the sites to operate and may be used to deliver you different content, depending on the type of investor you are.

You can block cookies by activating the setting on your browser which allows you to refuse the setting of all or some cookies. However, if you use your browser settings to block all cookies (including essential cookies) you may not be able to access all or part of our sites. Unless you have adjusted your browser setting so that it will refuse cookies, our system will issue cookies as soon as you visit our sites.


We store and use information you provide as follows:

  • to present content effectively;
  • to provide you with information, products or services that you request from us or which may interest you, tailored to your specific interests, where you have consented to be contacted for such purposes;
  • to carry out our obligations arising from any contracts between you and us;
  • to enable you to participate in interactive features of our service, when you choose to do so;
  • to notify you about changes to our service;
  • to improve our content by tracking group information that describes the habits, usage, patterns and demographics of our customers.

We may also send you emails to provide information and keep you up to date with developments on our sites. It is our policy to have instructions on how to unsubscribe so that you will not receive any future e-mails. You can change your e-mail address at any time.

In order to provide support on the usage of our tools, our support team need access to all information provided in relation to the tool.

We will not disclose your name, email address or postal address or any data that could identify you to any third party without first receiving your permission.

However, you agree that we may disclose to any regulatory authority to which we are subject and to any investment exchange on which we may deal or to its related clearing house (or to investigators, inspectors or agents appointed by them), or to any person empowered to require such information by or under any legal enactment, any information they may request or require relating to you, or if relevant, any of your clients.

You agree that we may pass on information obtained under Money Laundering legislation as we consider necessary to comply with reporting requirements under such legislation.


We want to ensure that the personal information we hold about you is accurate and up to date. You may ask us to correct or remove information that is inaccurate.

You have the right under data protection legislation to access information held about you. If you wish to receive a copy of any personal information we hold, please write to us at 3rd Floor, Hollywood House, Church Street East, Woking, GU21 6HJ. Any access request may be subject to a fee of £10 to meet our costs in providing you with details of the information we hold about you.


The data that we collect from you may be transferred to, and stored at, a destination outside the European Economic Area (“EEA”). It may be processed by staff operating outside the EEA who work for us or for one of our suppliers. Such staff may be engaged in, amongst other things, the provision of support services. By submitting your personal data, you agree to this transfer, storing and processing. We will take all steps reasonably necessary, including the use of encryption, to ensure that your data is treated securely and in accordance with this privacy policy.

Unfortunately, the transmission of information via the internet is not completely secure. Although we will do our best to protect your personal data, we cannot guarantee the security of your data transmitted to our sites; any transmission is at your own risk. You will not hold us responsible for any breach of security unless we have been negligent or in wilful default.


Any changes we make to our privacy policy in the future will be posted on this page and, where appropriate, notified to you by e-mail.


Our sites contain links to other websites. If you follow a link to any of these websites, please note that these websites have their own privacy policies and that we do not accept any responsibility or liability for these policies. Please check these policies before you submit any personal data to these websites.


If you want more information or have any questions or comments relating to our privacy policy please email in the first instance.

 Information  X 
Enter a valid email address

Recent News

Friday 23 April, 2010

23-Apr-2010 05:00 PM

Market Movers - Top risers and fallers at 17:00

FTSE 100 CARNIVAL ORD USD 1.66 2850.00 5.87% WOLSELEY ORD 10P 1658.00 5.40% INTERCON. HOTEL ORD 13 29/47P 1122.00 4.37% KINGFISHER ORD 15 5/7P 247.80
23-Apr-2010 05:00 PM

PLUSquoted Market Movers - Top risers and fallers at 17:00

PLUS Market Story provided by Business Financial Newswire...
23-Apr-2010 04:31 PM

Schlumberger first quarter revenues fall

Oilfield services giant Schlumberger's first-quarter revenue fell to $5.60bn - down from $5.74bn in the fourth quarter and $6bn a yedar ago. Income from continuing operations attributable to Schlumberger, before charges, was $747m ? a decrease of
23-Apr-2010 04:30 PM

Market Movers - Top risers and fallers between 15:00 and 16:00

Overall Market M&G EQ.IT CAP. CAP SHS 1P 2.38 11.74% CEPS ORD 5P 27.50 10.00% STOCKCUBE ORD 10P 16.50 6.45% LAGAN CAP. ORD 1P 11.50
23-Apr-2010 04:16 PM

Metroelectric reveals first trading profit

Metroelectric made a trading profit for the first time since its inception between the beginning of July and the end of March. It said sales for the period totalled £195,663. It says this period includes all the associated costs of the recent Powabyke a
23-Apr-2010 04:10 PM

Great Western Mining sets out Nevada plans

Great Western Mining - which has rights over 34 square kilometres of mineral claims in Nevada - is planning to implement a programme of geophysical survey, core hole drilling and geological evaluation. The recent costs associated with increasing the
23-Apr-2010 04:02 PM

HC Slingsby sales down 19%

Industrial and commercial equipment specialist HC Slingsby's pre-tax profits for the year to the end of December fell to £1m - down from £1.6m last time. Sales fell by 19% to £15.8m from £19.6m and operating prolfits were down at £1.3m from £1.6m.
23-Apr-2010 04:00 PM

Market Movers - Top risers and fallers at 16:00

FTSE 100 CARNIVAL ORD USD 1.66 2851.00 5.91% WOLSELEY ORD 10P 1657.00 5.34% INTERCON. HOTEL ORD 13 29/47P 1123.00 4.47% BR.AIRWAYS ORD 25P 234.90
23-Apr-2010 03:52 PM

UKCPT reviews merger proposal

UK Commercial Property Trust is reviewing a proposed with F&C Commercial Property Trust. The firm said it noted the announcement by FCPT and was reviewing a proposal from UKCPT's investment manager, Ignis Investment Services, regarding a proposed me
23-Apr-2010 03:47 PM

John Botts joins Songbird Estates board

Songbird Estates has appointed John Botts as the second independent director. he will work alongside independent non-executive chairman David Pritchard and the other board members. Botts, 69, is chairman of the investment company Botts & Co and senior a
23-Apr-2010 03:38 PM

Metroelectric first half losses widen

Metroelectric posts a pre-tax loss of £28,742 for the six months to the end of December - up from £26,041 last time. Turnover for the period was £49,963 and the firm had cash at bank and in hand of £16,598 compared with £22,600 a year ago. Chairman Greg
23-Apr-2010 03:30 PM

Market Movers - Top risers and fallers between 14:00 and 15:00

Overall Market GROUPE EURO. ORD EUR0.4 7.54 11.70% SLIMMA ORD 5P 7.00 7.69% INTELLEGO HLGDS ORD 0.05P 0.38 7.14% NICHE GRP. ORD 1P 3.17
23-Apr-2010 03:29 PM

Shire sues Teva over infringing patents

Specialty biopharmaceutical firm Shire has filed a US lawsuit against Teva Pharmaceuticals for infringing two patents. The lawsuit was filed by Shire's subsidiary - Shire LLC - in the US District Court of Delaware against Teva Pharmaceuticals USA
23-Apr-2010 03:21 PM

Takashi Yasuda joins Kalahari Minerals board

Kalahari Minerals has appointed Takashi Yasuda as a non-executive director with immediate effect. This appointment follows the strategic investment made in Kalahari by the major Japanese trading house, ITOCHU Corporation through its wholly-owned subsidi
23-Apr-2010 03:05 PM

US new home sales up 26.9%

Sales of new single-family houses rose in March to seasonally adjusted annual rate of 411,000, estimates released today (23 April) by the US Commerce Department and the Department of Housing and Urban Development show. This is 26.9% up on the revised Fe
23-Apr-2010 03:00 PM

Pfizer halts liver cancer drug trial

Pfizer has stopped a phase-3 study of its drug Sutent (sunitinib malate) as a treatment for liver cancer. Pfizer said the study was discontinued based on a higher incidence of serious adverse events in the sunitinib arm compared to the sorafenib arm and
23-Apr-2010 03:00 PM

Market Movers - Top risers and fallers at 15:00

FTSE 100 WOLSELEY ORD 10P 1654.00 5.15% CARNIVAL ORD USD 1.66 2826.00 4.98% INTERCON. HOTEL ORD 13 29/47P 1118.00 4.00% KINGFISHER ORD 15 5/7P 247.30
23-Apr-2010 02:54 PM

Court sanctions Avisen takeover of Xploite

A scheme of arrangement for business performance specialist Avisen's acquisition of Xploite was sanctioned by the High Court today (23 April). A hearing to consider and, if thought fit, confirm the reduction of the share capital is scheduled to tak
23-Apr-2010 02:48 PM

Quayle Munro FY profits likely to beat expectations

Quayle Munro Holdings' full year underlying profits are likely to exceed expectations. In its interim report for the period ended 31 December the firm said there was well-advanced activity on a number of retained clients and other transactions which
23-Apr-2010 02:43 PM

NetPlayTV clinches deal for ITV1's 'The Zone'

Interactive gaming company NetPlayTV has clinched a significant airtime deal for the new ITV1 night time teleshopping trial window, 'The Zone'. It says the deal marks another milestone in the company's goal of becoming the UK's leadi
23-Apr-2010 02:36 PM

SDL revenue and profit in line for Q1

Global information management solutions specialist SDL's first quarter revenue and operating profits are in line with expectations. It says: "While management remains cautious in its sentiment towards sustained global economic recovery we see s
23-Apr-2010 02:32 PM

Noble Investments sets date for interims

Noble Investments will be announcing its interim results for the six months to the end of February on 28 April. Story provided by Business Financial Newswire...
23-Apr-2010 02:30 PM

Market Movers - Top risers and fallers between 13:00 and 14:00

Overall Market CREAT RES LD ORD NPV (DI) 3.63 3.71% BILLING SERVICE COM SHS USD0.59446 18.25 2.82% SIRIUS EXPLORE ORD 0.25P 4.63 2.78% MAVINWOOD ORD 0.1P 0.59
23-Apr-2010 02:28 PM

Lilly responds to FDA over Bydureon

Amylin Pharmaceuticals, Eli Lilly and Co and Alkermes have submitted their reply to a complete response letter issued by the US Food and Drug Administration after review of the new drug application submission for Bydureon. The FDA is expected to classify
23-Apr-2010 02:11 PM

Fundy Minerals pulls out of Liberia

Fundy Minerals is withdrawing its operations from Liberia and surrendering its exploration permit. Chairman and chief executive Jeff Michel said the board had considered the implications the new Liberian Mining Act and concluded that it was not in